CPG 7909 Injection in Melanoma

计划入组 184 人 · 首次发布于 2003 年 10 月 8 日

CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas

计划入组 30 人 · 首次发布于 2005 年 9 月 16 日

A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated

计划入组 41 人 · 首次发布于 2005 年 10 月 5 日

ELI-002

rPA-7909

KBP-7909

Eli Lilly Nederland BV

Netherlands

ELI LILLY INTERAMERICA INC

Colombia

Eli Lilly and Company

Costa Rica

IDMC Recommends Continuation of ELI-002 7P Phase 2 Trial in Pancreatic Cancer Following Positive Interim Analysis

Elicio Therapeutics Gains FDA Support for ELI-002 Registrational Strategy in KRAS-Mutated Cancers

Elicio Therapeutics Completes Enrollment in Phase 2 Trial of ELI-002 for mKRAS-Driven Pancreatic Cancer